CLLS – cellectis s.a. - american depositary shares (US:NASDAQ)

News

Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells
Cellectis GAAP EPS of $0.01 beats by $0.24, revenue of $37.16M [Seeking Alpha]
Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update
Cellectis to Present a Development Update for eti-cel at ASH 2025
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com